First experience of using a hypothermic perfusion machine in kidney transplant in Argentina

  • Rubén Schiavelli División Nefrología y Trasplante Renal Hospital Argerich
  • Nicolás Sánchez Ente Autárquico Instituto de Trasplante
  • Leandro Mosna Ente Autárquico Instituto de Trasplante
  • José Luis Menna Ente Autárquico Instituto de Trasplante
  • Gabriela Fuentes Ente Autárquico Instituto de Trasplante
  • Gabriela Hidalgo Guardia Médica INCUCAI
  • Andrea Vila Unidad Quirófano, Hospital Argerich
  • Leonel Vega Unidad Quirófano, Hospital Argerich
  • Julieta Raño División Nefrología y Trasplante Renal Hospital Argerich
  • Josefina Roses División Nefrología y Trasplante Renal Hospital Argerich
  • Liliana Bisigniano Dirección Científico Técnica INCUCAI
  • Ariel Antik Dirección Científico Técnica INCUCAI
  • Víctor Mera División Anatomía Patológica, Hospital Argerich
  • Laura López Moral División laboratorio Central, Hospital Argerich
  • María Ángeles Yrbas Coordinadora de la Unidad de Calidad y Evaluación de Procesos, INCUCAI
  • Martín Ajzenszlos Unidad Infectología, Hospital Argerich
  • Elena Maiolo Jefa de División de Infecciosas, Hospital de Infecciosas Francisco Javier Muñiz. GCBA
  • Carlos Soratti Presidencia INCUCAI
Keywords: Donors with expanded criteria, Hypothermic perfusion machine, Organ preservation, Organ allocation policy

Abstract

Introduction: Argentina has high rates of delayed graft function (DGF). Renal machine perfusion decreases DGF. INCUCAI incorporated two renal perfusion machines (RPMs) into the transplant system and chose Argerich Hospital for their implementation. Objective: To assess the logistics, safety, and coordination of incorporating RPMs in Argentina. Methods: Travel times were assessed; culture tests of pre- and post-perfusion preservation solutions were performed. Results: Ten previously discarded deceased donor kidneys were perfused without complications. Conclusion: The times observed were as expected from our healthcare system. The procedure was safe, with equal or less isolation of germs after perfusion. This first experience in Argentina shows INCUCAI’s incorporation of new transplant technology and Argerich Hospital’s optimal adaptation to this practice.

Published
2024-12-11
How to Cite
1.
Schiavelli R, Sánchez N, Mosna L, Menna JL, Fuentes G, Hidalgo G, Vila A, Vega L, Raño J, Roses J, Bisigniano L, Antik A, Mera V, López Moral L, Yrbas M Ángeles, Ajzenszlos M, Maiolo E, Soratti C. First experience of using a hypothermic perfusion machine in kidney transplant in Argentina. Rev Nefrol Dial Traspl. [Internet]. 2024Dec.11 [cited 2024Dec.27];44(04):182-9. Available from: http://vps-1689312-x.dattaweb.com/index.php/rndt/article/view/994
Section
Original Article